Harvard Corporate Governance
MAY 28, 2022
Bebchuk and Roberto Tallarita (discussed on the Forum here ); Companies Should Maximize Shareholder Welfare Not Market Value by Oliver Hart and Luigi Zingales (discussed on the Forum here ); Reconciling Fiduciary Duty and Social Conscience: The Law and Economics of ESG Investing by a Trustee by Max M. percent in 2021, up from 29.2
Harvard Corporate Governance
MARCH 24, 2022
The global IPO market made up for lost time in 2021. A proportion of last year’s activity reflected pent-up demand, with new issues that might have taken place in the previous year deferred until 2021. Nevertheless, excluding SPACs, the IPO market still enjoyed a record year, with 2,340 new issues raising US$428.9
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Exit Strategy
JUNE 28, 2022
Financing Deals in 2021 Presented by IBBA & M&A Source Deal financing has not changed significantly since before the pandemic. The post Market Pulse – Q4 2021 appeared first on Exit Strategies Group, Inc. . […]. The post Market Pulse – Q4 2021 appeared first on Exit Strategies Group, Inc.
BVR
MARCH 28, 2022
The 2021 Discount for Lack of Marketability Study provides objective rate of return measures to implement the Johnson/Park empirical method for determining a discount for lack of marketability (DLOM) for the valuation of interests in privately held corporations and partnerships.
Harvard Corporate Governance
AUGUST 19, 2022
CFO turnover is running high, with 2021 surpassing 2020 and 2019 churn rates, Russell Reynolds Associates’ recent analysis of the S&P 500 revealed. In 2021, there were 89 CFO transitions in the S&P 500, bringing CFO turnover to 18%—the highest its been in the past few years.
Exit Strategy
MAY 6, 2022
Seller’s Market Presented by IBBA & M&A Source A seller’s market occurs when demand exceeds supply. There are more interested, active buyers than there are quality deals on the market. In a seller’s market, buyer’s compete in order to win deals.
Fox Corporate Finance
DECEMBER 16, 2021
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Pharmaceutical Market Study – 2021”. Based on available data from European pharmaceutical providers, the FCF Pharmaceutical Market Study is a detailed and comprehensive.
Expert insights. Personalized for you.
238 
Let's personalize your content